AGNSS

Showing 3 posts of 3 posts found.

Solaris image

NICE backs world’s most expensive medicine

September 4, 2014
Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris

In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …

abpi_reception

NHS needs to understand drug costs better, says ABPI

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, AGNSS, Deepak Khanna, NICE, Stephen Whitehead, Tarceva, soliris

The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …

NICE image

NICE to assess high cost drugs for rare conditions

July 24, 2012
Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions

NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …

Latest content